Free Trial

Yale Jen Analyst Performance

Analyst at Laidlaw

Yale Jen is a stock analyst at Laidlaw focused in the medical sector, covering 10 publicly traded companies. Over the past year, Yale Jen has issued 4 stock ratings, including and buy recommendations. While full access to Yale Jen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yale Jen's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
11 Last 11 Years
Buy Recommendations
90.91% 10 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy90.9%10 ratings
Hold9.1%1 ratings
Sell0.0%0 ratings

Out of 11 total stock ratings issued by Yale Jen at Laidlaw, the majority (90.9%) have been Buy recommendations, followed by 9.1% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
90.0% of companies on NASDAQ
9 companies
NYSEAMERICAN
10.0% of companies on NYSEAMERICAN
1 company

Yale Jen, an analyst at Laidlaw, currently covers 10 companies listed on NASDAQ and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
7 companies
70.0%
Computer and Technology
2 companies
20.0%
Manufacturing
1 company
10.0%

Yale Jen of Laidlaw specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
4 companies
40.0%
PHARMACEUTICAL PREPARATIONS
2 companies
20.0%
MED - DRUGS
2 companies
20.0%
COMP - SOFTWARE
1 company
10.0%
INTERNET SOFTWARE
1 company
10.0%

Yale Jen's Ratings History at Laidlaw

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Novogen Limited stock logo
KZIA
Novogen
4/15/2026Initiated Coverage$9.46$25.00Buy
PTN
Palatin Technologies
12/12/2025Initiated Coverage$24.67$60.00Buy
Femasys Inc. stock logo
FEMY
Femasys
11/20/2025Initiated Coverage$0.76$6.50Buy
Senti Biosciences, Inc. stock logo
SNTI
Senti Biosciences
6/6/2025Initiated Coverage$3.56$5.00Buy
icad inc. stock logo
ICAD
icad
4/17/2025Reiterated Rating$3.07Hold
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3/27/2025Boost Price Target$68.01$105.00Buy
Nuvectis Pharma, Inc. stock logo
NVCT
Nuvectis Pharma
3/17/2025Initiated Coverage$8.85$19.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
2/10/2025Initiated Coverage$16.80$120.00Buy